2
Clinical Trials associated with Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical)评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群接种的免疫原性和安全性的Ⅱ期临床试验
[Translation] Phase II clinical trial evaluating the immunogenicity and safety of recombinant zoster vaccine (CHO cells) in individuals aged 40 years and older.
主要目的:
评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群中接种的免疫原性;
次要目的:
评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群中接种的安全性;
探索重组带状疱疹疫苗(CHO细胞)不同免疫程序在40周岁及以上人群中接种的免疫原性。
[Translation] Primary objective: To evaluate the immunogenicity of recombinant zoster vaccine (CHO cells) in individuals aged 40 years and older;
Secondary objectives: To evaluate the safety of recombinant zoster vaccine (CHO cells) in individuals aged 40 years and older; To explore the immunogenicity of different immunization schedules of recombinant zoster vaccine (CHO cells) in individuals aged 40 years and older.
/ Active, not recruitingPhase 1 评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群使用的安全性和免疫原性的Ⅰ期临床试验
[Translation] A Phase I clinical trial to evaluate the safety and immunogenicity of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群使用的安全性和免疫原性的Ⅰ期临床试验
[Translation] A Phase I clinical trial to evaluate the safety and immunogenicity of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
100 Clinical Results associated with Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical)
100 Translational Medicine associated with Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical)
100 Patents (Medical) associated with Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical)
100 Deals associated with Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical)